- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06683781
Ventilatory Settings and Monitoring Variables Associated With Weaning Failure in Critically Ill Patients (WEAN-FAIL)
Ventilatory Settings and Monitoring Variables Associated With Weaning Failure in Critically Ill Patients: A Retrospective Study
Mechanical ventilation (MV) is essential in managing acute respiratory failure. Its duration is a crucial aspect since both, unnecessary prolongation and premature withdrawal have deleterious effects on patient outcomes in the ICU. The process of weaning refers to the set of procedures and evaluations carried out to discontinue MV. Regardless of the definition used, within the population undergoing weaning, there is a group of patients who successfully pass the daily screening but fail the spontaneous breathing trial (SBT) or the separate attempt (SA). In Argentina, this figure is 39.5%, and 31.4% in patients with COVID-19. On the other hand, another group of patients successfully passes the SA, is extubated, but fails in post-extubation. This failure rate varies in the literature, ranging from approximately 10 to 20%. In our country, this figure is 16% in the general population and rises to 29.7% in COVID-19 patients. Additionally, this population is divided into those who cannot tolerate ventilation without an artificial airway due to upper airway patency issues (such as laryngeal edema), i.e., "airway failure," and those who experience acute respiratory failure. In 2023, the WEAN SAFE study reported novel findings regarding variables associated with weaning failure. In multivariable analysis, it was found that the MV settings and monitoring variables at the time of the first SBT - respiratory rate, positive end-expiratory pressure (PEEP), dynamic airway pressure difference (peak pressure (Ppeak) minus PEEP) on the day of the SA - were associated with weaning failure. In this context, the investigators will conduct a retrospective cohort study, whose primary objective will be to assess which MV settings and monitoring variables are associated with weaning failure.
**Primary Objective** To determine if there are any MV settings or monitoring variables that are associated with extubation failure.
**Secondary Objective** To determine if there are any MV settings or monitoring variables that are associated with failure in the first SBT.
Study Overview
Status
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Emilio M Steinberg, RT
- Phone Number: 7528 +54 11 4959-0200
- Email: emilio.steinberg@hiba.org.ar
Study Contact Backup
- Name: Damián E Steinberg, RT
- Email: damianedstein@gmail.com
Study Locations
-
-
-
Ciudad Autónoma de Buenos Aires, Argentina, 1199
- Recruiting
- Hospital Italiano de Buenos Aires
-
Contact:
- Emilio M Steinberg, RT
- Phone Number: 7528 +54 11 4959-0200
- Email: emilio.steinberg@hospitalitaliano.org.ar
-
Sub-Investigator:
- Mariano Setten, RT
-
Sub-Investigator:
- Luis I Garegnani, RT
-
Sub-Investigator:
- Damián E Steinberg, RT
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Over 18 years
- MV for at least 48 hours, regardless of the cause of onset
- Undergone at least one extubation, regardless of the outcome
- At least one spontaneous breathing trial (SBT) during their ICU stay, regardless of the outcome
Exclusion Criteria:
- MV records containing incorrect or inconsistent data
- did not have adequate or continuous monitoring during the weaning process
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Mechanically ventilated patients
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of participants with extubation failure
Time Frame: 7 days
|
Need for reintubation within the first 7 days after the removal of the endotracheal tube, regardless of the cause that precipitates it.
|
7 days
|
|
Cause of reintubation
Time Frame: 7 days
|
Reason that precipitates the need for reinsertion of the endotracheal tube.
|
7 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Spontaneous breathing trial failure
Time Frame: Immediately after spontaneous breathing trial
|
Rate of restoring invasive MV due to objective or subjective signs.
|
Immediately after spontaneous breathing trial
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 7221
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.